Nanobiotix S.A. (NBTX)

NASDAQ: NBTX · IEX Real-Time Price · USD
-0.03 (-0.33%)
At close: Jan 19, 2022 4:00 PM
-0.69 (-7.68%)
After-hours:Jan 21, 2022 4:00 PM EST

Total Valuation

Nanobiotix has a market cap or net worth of $312.60 million. The enterprise value is $251.15 million.

Market Cap312.60M
Enterprise Value251.15M

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Nanobiotix has 34.81 million shares outstanding.

Shares Outstanding34.81M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)11.76%

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ratio124.44
PB Ratio6.34
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

EV / Earningsn/a
EV / Sales99.98
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 3.05, with a Debt / Equity ratio of 1.22.

Current Ratio3.05
Quick Ratio2.69
Debt / Equity1.22
Debt / EBITDAn/a
Debt / FCFn/a

Financial Efficiency

Return on Equity (ROE)n/a
Return on Assets (ROA)n/a
Return on Capital (ROIC)n/a
Revenue Per Employee$25,633
Profits Per Employee-$342,755
Employee Count98
Asset Turnovern/a
Inventory Turnovern/a


Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

Beta (1Y)2.31
Total Price Change-53.69%
50-Day Moving Average8.24
200-Day Moving Average11.16
Average Volume (30 Days)5,079

Short Selling Information

Short Interest1,118
Short % of Shares Out0.00%
Short % of Float0.00%
Short Ratio (days to cover)0.14

Income Statement

In the last 12 months, Nanobiotix had revenue of 2.51 million and -33.59 million in losses. Earnings per share was -$1.62.

Gross Profitn/a
Operating Incomen/a
Net Income-33.59M
Earnings Per Share (EPS)-$1.62
Full Income Statement

Balance Sheet

The company has $121.83 million in cash and $60.38 million in debt, giving a net cash position of $61.45 million or $1.77 per share.

Cash & Cash Equivalents121.83M
Total Debt60.38M
Net Cash61.45M
Net Cash Per Share$1.77
Book Value49.32M
Book Value Per Share1.42
Working Capital92.66M
Full Balance Sheet

Cash Flow

Operating Cash Flown/a
Capital Expendituresn/a
Free Cash Flown/a
FCF Per Sharen/a
Full Cash Flow Statement


Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Margin-1,337.18%
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Nanobiotix does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-10.75%
FCF Yieldn/a
Dividend Growth (YoY)n/a
Payout Ration/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Daten/a
Split Typen/a
Split Ration/a